Stock Updates

Is this Large Market Cap Stock target price reasonable for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)?

The company in question is, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) currently with a stock price of 95.95 (1.02% today). The market cap for Vertex Pharmaceuticals Incorporated is 23323.29, and is in the sector Healthcare, and Biotechnology industry. The target price for Vertex Pharmaceuticals Incorporated is 109.16. Currently Vertex Pharmaceuticals Incorporated is trading with a P/E of *TBA, and a forward P/E of 30.13. Average volume for Vertex Pharmaceuticals Incorporated is 1671.47 and so far today it is 899891.

Performance in the last year for Vertex Pharmaceuticals Incorporated has been -22.92%. For EPS growth, Vertex Pharmaceuticals Incorporated has seen a growth of 26.50%, and is looking to grow in the next year to 207.81%. More long term stats show that EPS growth has been 9.30% over the last five years and could be 51.20% for the next five years. Vertex Pharmaceuticals Incorporated has seen sales growth quarter over quarter at 187.40%, with EPS growth quarter over quarter at 79.40%. The 20-day simple moving average is 7.94%, with the 200-day simple moving average coming to -2.31%.

Since the IPO date for Vertex Pharmaceuticals Incorporated on the 7/24/1991, Vertex Pharmaceuticals Incorporated has seen performance year to date to be -24.52%. With Vertex Pharmaceuticals Incorporated trading at 95.95, the dividend yield is *TBA, and the EPS is -1.65.

So could Vertex Pharmaceuticals Incorporated, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 18.05 and the P/B is at 24.17. The P/cash is 22.74, with P/free cash flow at *TBA.

Vertex Pharmaceuticals Incorporated ability to deal with debt shows that the current ratio is 2.5, and the quick ratio is 2.4. This is with long term debt/equity at 0.69, and total debt/equity at 0.86.

In terms of margins, Vertex Pharmaceuticals Incorporated has a gross margin of 87.80%, an operating margin of -23.90% and a profit margin of -30.90%.Payout ratio for Vertex Pharmaceuticals Incorporated is *TBA. Return on assets come to -16.30% with return on investment coming to -28.20%.

Insider ownership for Vertex Pharmaceuticals Incorporated, is at 0.50% and institutional ownership comes to 97.00%. Outstanding shares are at 245.56. While shares float is 245.56. The float short is currently 2.75%, and short ratio is 4.04.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment